Home › Companies › EMERGENT BIOSOLUTIONS INC. › 2023-2024

EMERGENT BIOSOLUTIONS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and EMERGENT BIOSOLUTIONS INC.’s Form 8-K, filed 2024-05-29 (Item 5.07 on EDGAR). Page generated 02 October 2026.

7Reported items
159Asset managers
941Fund votes
2024-05-23Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore EMERGENT BIOSOLUTIONS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by EMERGENT BIOSOLUTIONS INC.

These tallies are EMERGENT BIOSOLUTIONS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-29 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

EMERGENT BIOSOLUTIONS INC. — official shareholder meeting results, meeting held 2024-05-23
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Donald DeGolyer	23,613,429	--	--	906,655	13,259,108	Majority: yes
Elect Director: Neal Fowler	23,476,806	--	--	1,043,278	13,259,108	Majority: yes
Elect Director: Marvin White	15,374,307	--	--	9,145,777	13,259,108	Majority: yes
Proposal 2: approved. The voting results were as follows:	36,285,391	1,370,317	123,484	--	--	Majority: yes
Proposal 3: approved. The voting results were as follows:	23,648,074	693,485	178,525	--	13,259,108	Majority: yes
Proposal 4: approved. The voting results were as follows:	19,209,834	5,137,504	172,746	--	13,259,108	Majority: yes

Source: EMERGENT BIOSOLUTIONS INC., Form 8-K, filed with the SEC on 2024-05-29 — read the filing on EDGAR.

How asset managers voted at the EMERGENT BIOSOLUTIONS INC. 2023-2024 meeting

Each item below shows how the 159 asset managers that disclosed a EMERGENT BIOSOLUTIONS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of EMERGENT BIOSOLUTIONS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers;

SECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

99.6% fund support · no official result

FOR 99.6%

The 154 asset managers below cast 99.6% of the shares they voted on this item FOR (26,135,808 for, 97,341 against).

FOR: 26,135,808 (99.6%)AGAINST: 97,341 (0.4%)

Largest asset managers voting on “To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive officers;” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset manager	For	Vote
Charles Schwab	7,675,080	For
BlackRock	5,130,811	For
Vanguard	3,270,548	For
Avidity Partners Management LP	1,448,811	For
Invesco	1,113,714	For
State Street	800,032	For
Connor, Clark & Lunn Investment Management Ltd.	675,561	For
STRS OHIO	604,700	For
BRIDGEWAY CAPITAL MANAGEMENT, LLC	591,933	For
BRIDGEWAY FUNDS INC	546,233	For
AQR	352,625	For
American Century	351,528	For
Prudential/PGIM	292,110	For
PALISADE CAPITAL MANAGEMENT, LP	265,372	For
Northern Trust	261,157	For
SEI	239,136	For
Two Sigma	232,761	For
DE Shaw	219,812	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	210,129	For
NEW YORK STATE COMMON RETIREMENT FUND	153,404	For
FULLER & THALER ASSET MANAGEMENT, INC.	139,875	For
Dimensional	135,928	For
TEACHER RETIREMENT SYSTEM OF TEXAS	107,263	For
TARGET PORTFOLIO TRUST	92,900	For
QUANTITATIVE MASTER SERIES LLC	86,397	For

Showing the 25 largest of 154 asset managers. See all 154 in the interactive database.

2. To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Donald DeGolyer

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 23,613,429WITHHELD: 906,655

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Donald DeGolyer”): 23,613,429 for, 906,655 withheld, per its Form 8-K filed 2024-05-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,400,000 outstanding shares: 45.1% for, 2% withheld (46.8% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (12,157,232 for, 0 against).

FOR 99.8%

FOR: 12,157,232 (99.9%)ABSTAIN: 13,396 (0.1%)

Largest asset managers voting on “To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholde” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	3,837,540	0	For
Vanguard	3,245,017	0	For
BlackRock	2,798,702	0	For
BRIDGEWAY FUNDS INC	546,233	0	For
Invesco	546,125	0	For
American Century	174,548	0	For
SEI	117,724	0	For
Capitol Series Trust	100,900	0	For
TARGET PORTFOLIO TRUST	92,900	0	For
QUANTITATIVE MASTER SERIES LLC	86,397	0	For
MASTER INVESTMENT PORTFOLIO	86,300	0	For
State Street	75,158	0	For
Equitable	63,533	0	For
Prudential/PGIM	62,100	0	For
Lincoln Financial	50,355	0	For
AQR	42,673	0	For
Northern Trust	33,000	0	For
Fidelity	27,023	0	For
AIG/SunAmerica	25,629	0	For
Bridge Builder Trust	21,173	0	For
Pacific Life	20,072	0	For
New York Life	14,059	0	For
Amplify ETF Trust	0	13,396	Abstain
John Hancock	13,253	0	For
Blackstone Alternative Investment Funds	12,000	0	For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

3. To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Marvin White

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

63% Majority: yes · of votes cast

FOR 63%WITHHELD 37%

FOR: 15,374,307WITHHELD: 9,145,777

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Marvin White”): 15,374,307 for, 9,145,777 withheld, per its Form 8-K filed 2024-05-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,400,000 outstanding shares: 29% for, 17% withheld (46.8% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (7,507,932 for, 0 against).

FOR 62%ABSTAIN 38%

FOR: 7,507,932 (61.7%)ABSTAIN: 4,662,696 (38.3%)

Largest asset managers voting on “To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholde” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	0	3,837,540	Abstain
Vanguard	3,245,017	0	For
BlackRock	2,798,702	0	For
BRIDGEWAY FUNDS INC	0	546,233	Abstain
Invesco	546,125	0	For
American Century	174,548	0	For
SEI	0	117,724	Abstain
Capitol Series Trust	100,900	0	For
TARGET PORTFOLIO TRUST	92,900	0	For
QUANTITATIVE MASTER SERIES LLC	86,397	0	For
MASTER INVESTMENT PORTFOLIO	86,300	0	For
State Street	68,845	6,313	For
Equitable	9,533	54,000	Abstain
Prudential/PGIM	62,100	0	For
Lincoln Financial	0	50,355	Abstain
AQR	42,673	0	For
Northern Trust	0	33,000	Abstain
Fidelity	27,023	0	For
AIG/SunAmerica	25,629	0	For
Bridge Builder Trust	21,173	0	For
Pacific Life	20,072	0	For
New York Life	14,059	0	For
Amplify ETF Trust	13,396	0	For
John Hancock	10,577	2,676	For
Blackstone Alternative Investment Funds	12,000	0	For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

4. To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholders, each to serve and until their respective successors are duly elected and qualified: Neal Fowler

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 23,476,806WITHHELD: 1,043,278

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Neal Fowler”): 23,476,806 for, 1,043,278 withheld, per its Form 8-K filed 2024-05-29 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,400,000 outstanding shares: 45% for, 2% withheld (46.8% of the company cast a for/withheld vote).

The 47 asset managers below cast 100% of the shares they voted on this item FOR (12,170,628 for, 0 against).

FOR 100%

FOR: 12,170,628 (100.0%)

Largest asset managers voting on “To elect three Class III directors to hold office for a term expiring at our 2027 Annual Meeting of Stockholde” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset manager	For	Vote
Charles Schwab	3,837,540	For
Vanguard	3,245,017	For
BlackRock	2,798,702	For
BRIDGEWAY FUNDS INC	546,233	For
Invesco	546,125	For
American Century	174,548	For
SEI	117,724	For
Capitol Series Trust	100,900	For
TARGET PORTFOLIO TRUST	92,900	For
QUANTITATIVE MASTER SERIES LLC	86,397	For
MASTER INVESTMENT PORTFOLIO	86,300	For
State Street	75,158	For
Equitable	63,533	For
Prudential/PGIM	62,100	For
Lincoln Financial	50,355	For
AQR	42,673	For
Northern Trust	33,000	For
Fidelity	27,023	For
AIG/SunAmerica	25,629	For
Bridge Builder Trust	21,173	For
Pacific Life	20,072	For
New York Life	14,059	For
Amplify ETF Trust	13,396	For
John Hancock	13,253	For
Blackstone Alternative Investment Funds	12,000	For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

5. To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan.

COMPENSATION

91% fund support · no official result

FOR 91%9%

The 47 asset managers below cast 91% of the shares they voted on this item FOR (11,026,000 for, 1,043,812 against).

FOR: 11,026,000 (91.4%)AGAINST: 1,043,812 (8.6%)

Largest asset managers voting on “To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan.” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset manager	For	Against	Vote
Charles Schwab	3,837,540	0	For
Vanguard	3,245,017	0	For
BlackRock	2,798,702	0	For
BRIDGEWAY FUNDS INC	0	546,233	Against
Invesco	546,125	0	For
American Century	0	174,548	Against
SEI	117,724	0	For
TARGET PORTFOLIO TRUST	92,900	0	For
QUANTITATIVE MASTER SERIES LLC	86,397	0	For
MASTER INVESTMENT PORTFOLIO	86,300	0	For
State Street	0	75,158	Against
Equitable	63,533	0	For
Prudential/PGIM	62,100	0	For
Lincoln Financial	0	50,355	Against
AQR	0	42,673	Against
Northern Trust	33,000	0	For
Fidelity	1,838	25,185	Against
AIG/SunAmerica	0	25,629	Against
Bridge Builder Trust	21,173	0	For
Pacific Life	20,072	0	For
New York Life	0	14,059	Against
Amplify ETF Trust	0	13,396	Against
John Hancock	0	13,253	Against
Blackstone Alternative Investment Funds	0	12,000	Against
T. Rowe Price	0	10,968	Against

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

6. To ratify the appointment by the audit and finance committee of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 46 asset managers below cast 99.8% of the shares they voted on this item FOR (12,056,332 for, 13,396 against).

FOR: 12,056,332 (99.9%)AGAINST: 13,396 (0.1%)

Largest asset managers voting on “To ratify the appointment by the audit and finance committee of Ernst & Young LLP as our independent registere” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset manager	For	Against	Vote
Charles Schwab	3,837,540	0	For
Vanguard	3,245,017	0	For
BlackRock	2,798,702	0	For
BRIDGEWAY FUNDS INC	546,233	0	For
Invesco	546,125	0	For
American Century	174,548	0	For
SEI	117,724	0	For
TARGET PORTFOLIO TRUST	92,900	0	For
QUANTITATIVE MASTER SERIES LLC	86,397	0	For
MASTER INVESTMENT PORTFOLIO	86,300	0	For
State Street	75,158	0	For
Equitable	63,533	0	For
Prudential/PGIM	62,100	0	For
Lincoln Financial	50,355	0	For
AQR	42,673	0	For
Northern Trust	33,000	0	For
Fidelity	27,023	0	For
AIG/SunAmerica	25,629	0	For
Bridge Builder Trust	21,173	0	For
Pacific Life	20,072	0	For
New York Life	14,059	0	For
Amplify ETF Trust	0	13,396	Against
John Hancock	13,253	0	For
Blackstone Alternative Investment Funds	12,000	0	For
T. Rowe Price	10,968	0	For

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

7. Advisory Vote to Ratify Named Executive Officers' Compensation

COMPENSATION

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (101,090 for, 0 against).

FOR: 101,090 (100.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at EMERGENT BIOSOLUTIONS INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Capitol Series Trust	100,900	0	0	0	For
TD ASSET MANAGEMENT INC	190	0	0	0	For

Largest EMERGENT BIOSOLUTIONS INC. shareholders voting in 2023-2024

Ranked by the number of EMERGENT BIOSOLUTIONS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 52,400,000 shares outstanding at the time of that meeting.

Top EMERGENT BIOSOLUTIONS INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Charles Schwab	14.65%
2	BlackRock	9.79%
3	Vanguard	6.24%
4	Avidity Partners Management LP	2.76%
5	Invesco	2.13%
6	State Street	1.53%
7	Connor, Clark & Lunn Investment Management Ltd.	1.29%
8	STRS OHIO	1.15%
9	BRIDGEWAY CAPITAL MANAGEMENT, LLC	1.13%
10	BRIDGEWAY FUNDS INC	1.04%

Reported EMERGENT BIOSOLUTIONS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

EMERGENT BIOSOLUTIONS INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	8.14%	13F
Vanguard Group	6.76%	13F
Charles Schwab Investment Management, Inc.	5.48%	DEF14A
Geode Capital	2.14%	13F
State Street	2.02%	13F
AQR Capital	2.01%	13F
Two Sigma	1.93%	13F
Millennium Management	1.71%	13F
Invesco	1.70%	13F
Renaissance Technologies	1.70%	13F

Percentages above are of 52,400,000 shares outstanding, as reported by EMERGENT BIOSOLUTIONS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EMERGENT BIOSOLUTIONS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At EMERGENT BIOSOLUTIONS INC.'s shareholder meeting held 2024-05-23, in the 2023-2024 proxy season, 159 asset managers reported how they voted in their SEC Form N-PX filings, covering 941 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. EMERGENT BIOSOLUTIONS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To hold, on an advisory basis, a vote to approve the 2023 compensation of our named executive… — the reporting funds cast 99.6% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

EMERGENT BIOSOLUTIONS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.